Status:
NOT_YET_RECRUITING
Patient-centered REhabilitation Program to Advance REcovery
Lead Sponsor:
Korea University Anam Hospital
Conditions:
Cancer
Frailty
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn whether an app-based, patient-centered prehabilitation program improves preoperative functional capacity in adults scheduled for elective cancer surgery. Th...
Detailed Description
Overview and Rationale This multicenter, pragmatic, parallel-group randomized trial evaluates a minimal-cost, app-based, patient-centered prehabilitation program for adults undergoing elective cancer ...
Eligibility Criteria
Inclusion
- Adults ≥18 years.
- Elective cancer surgery planned under general anesthesia at a participating site (e.g., gastrointestinal, hepatobiliary-pancreatic, thoracic, gynecologic, or other site-approved cancer operations).
- Ambulatory: able to walk independently (assistive device such as a cane is allowed) and deemed safe to perform a six-minute walk test (6MWT) per investigator judgment.
- Smartphone access and app use: owns/has regular access to a smartphone capable of running the study app and agrees to use the app (notifications, weekly home 6MWT logging, brief daily check-ins).
- Preoperative lead-in: expected interval of ≈14 days or more between consent/randomization and surgery to allow prehabilitation exposure (shorter intervals may be screened but must allow minimum onboarding and at least one home 6MWT).
- Able to understand study procedures and provide written informed consent (Korean or English literacy sufficient to follow app instructions).
Exclusion
- Emergency surgery or surgery date that cannot accommodate even minimal prehabilitation onboarding.
- ASA IV or higher, or any unstable/critical condition that, in the investigator's opinion, makes participation unsafe.
- Contraindications to 6MWT/light walking, including but not limited to: unstable angina, recent myocardial infarction (≤30 days), decompensated heart failure, uncontrolled clinically significant arrhythmia, severe symptomatic aortic stenosis, severe uncontrolled pulmonary disease, or investigator-judged safety concerns (e.g., resting severe hypoxemia, high fall risk).
- Non-ambulatory status or musculoskeletal/neurologic conditions that preclude performing a 6MWT.
- Cognitive impairment or psychiatric/behavioral conditions that preclude informed consent or reliable app use.
- Inability or unwillingness to install/use the study app (or lack of regular smartphone access).
- Concurrent enrollment in another interventional clinical trial that would confound outcomes or burden participants (per investigator judgment).
- Any other medical or logistical condition that, in the opinion of the investigator, would interfere with protocol adherence, outcome assessment on the preoperative day, or the routine postoperative follow-up visit.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07189000
Start Date
January 1 2026
End Date
December 31 2027
Last Update
September 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Anam Hospital
Seoul, South Korea